Опухолевые маркеры в детской онкологии Учебно-методическое пособие

15.Woods W.G., Gao R.N., Schuster J.J., Robison L.L., Bernstein M., Weitzman S., et al. Screening of infants and mortality due to neuroblastoma. N Engl J Med 2002; 346:1041–6.

16.Silber J., Evans A.E., Fridman M. Models to predict outcome fro childhood neuroblastoma: the role of serum ferritin and tumour histology. Cancer Res 1991; 51:1426–33.

17.Hann H.L., Evans A.E., Cohen I.J., Leitmeyer J.E. Biologic differences between neuroblastoma stages IVs and IV. Measurement of serum ferritin and e-rosette inhibition in 30 children. N Engl J Med 1981; 305:425–9.

18.Hsiao R.J., Seeger R.C., Yu L.A., O’Connor D.T. Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival. J Clin Invest 1990; 85:1555–9.

19.Строганова А.М., Карселадзе А.И. Нейробластома: морфологическая структура, молекулярно-генетические особенности и прогностические факторы. Успехи молекулярной онкологии, 2016; 3: 32–43. DOI: 10.17650/2313-805X- 2016-3-1-32-43.

20